DE60210936D1 - Polypeptid, das neutralisierende antikörper gegen hiv induziert - Google Patents

Polypeptid, das neutralisierende antikörper gegen hiv induziert

Info

Publication number
DE60210936D1
DE60210936D1 DE60210936T DE60210936T DE60210936D1 DE 60210936 D1 DE60210936 D1 DE 60210936D1 DE 60210936 T DE60210936 T DE 60210936T DE 60210936 T DE60210936 T DE 60210936T DE 60210936 D1 DE60210936 D1 DE 60210936D1
Authority
DE
Germany
Prior art keywords
hiv
polypeptide
neutralizing antibodies
induces neutralizing
induces
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60210936T
Other languages
English (en)
Other versions
DE60210936T2 (de
Inventor
Robert Brasseur
Benoit Charloteaux
Michel Chevalier
Habib Raphaelle El
Tino Krell
Regis Sodoyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Sanofi Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0100141A external-priority patent/FR2819256B1/fr
Application filed by Sanofi Pasteur SA filed Critical Sanofi Pasteur SA
Publication of DE60210936D1 publication Critical patent/DE60210936D1/de
Application granted granted Critical
Publication of DE60210936T2 publication Critical patent/DE60210936T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60210936T 2001-01-05 2002-01-04 Polypeptid, das neutralisierende antikörper gegen hiv induziert Expired - Lifetime DE60210936T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0100141 2001-01-05
FR0100141A FR2819256B1 (fr) 2001-01-05 2001-01-05 Polypeptide induisant des anticorps neutralisant le vih
FR0100848 2001-01-23
FR0100848 2001-01-23
PCT/FR2002/000031 WO2002053587A2 (fr) 2001-01-05 2002-01-04 Polypeptide induisant des anticorps neutralisant le vih

Publications (2)

Publication Number Publication Date
DE60210936D1 true DE60210936D1 (de) 2006-06-01
DE60210936T2 DE60210936T2 (de) 2006-10-19

Family

ID=26212817

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210936T Expired - Lifetime DE60210936T2 (de) 2001-01-05 2002-01-04 Polypeptid, das neutralisierende antikörper gegen hiv induziert

Country Status (10)

Country Link
EP (1) EP1368478B1 (de)
AT (1) ATE324450T1 (de)
AU (1) AU2002229850A1 (de)
CA (1) CA2431881C (de)
CY (1) CY1105629T1 (de)
DE (1) DE60210936T2 (de)
DK (1) DK1368478T3 (de)
ES (1) ES2260416T3 (de)
PT (1) PT1368478E (de)
WO (1) WO2002053587A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005076001A2 (en) * 2004-02-06 2005-08-18 Inserm (Institut National De La Sante Et De La Recherche Medicale) A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
EP1445614A1 (de) * 2003-02-06 2004-08-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verfahren zur in vitro Überwachung der Entwicklung von HIV Virus eines Individuums
ES2366185T3 (es) * 2003-04-11 2011-10-18 Institut Pasteur Vacunas de péptidos sintéticas para vih: el epítopo de cbd como un inmunógeno eficaz para provocar anticuerpos ampliamente neutralizantes contra el vih.
WO2014020205A2 (es) * 2012-07-31 2014-02-06 Universidad De Granada Inmunógenos anti-vih mejorados
CN108997482A (zh) * 2018-08-09 2018-12-14 东莞市朋志生物科技有限公司 用于检测hiv-1的合成肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141211A0 (en) * 1998-08-03 2002-02-10 Univ Montana Prevention and treatment of viral disease
WO2000040616A1 (en) * 1999-01-08 2000-07-13 Panacos Pharmaceuticals, Inc. METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41

Also Published As

Publication number Publication date
WO2002053587A3 (fr) 2003-09-25
PT1368478E (pt) 2006-07-31
WO2002053587A2 (fr) 2002-07-11
DE60210936T2 (de) 2006-10-19
CY1105629T1 (el) 2010-12-22
EP1368478B1 (de) 2006-04-26
DK1368478T3 (da) 2006-08-28
ES2260416T3 (es) 2006-11-01
EP1368478A2 (de) 2003-12-10
CA2431881C (en) 2011-02-22
AU2002229850A1 (en) 2002-07-16
ATE324450T1 (de) 2006-05-15
CA2431881A1 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
BR0014282A (pt) Vacinas
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
MXPA02007478A (es) Vacuna contra el virus de inmunodeficiencia humana.
DE60125797D1 (de) Impfstoffzusammesetzung
CL2008003938A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00).
DK1328547T3 (da) Identifikation og modifikation af immundominante epitoper i polypeptider
CY1114614T1 (el) Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
WO2005089231A3 (en) Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide
DE60239682D1 (de) Vakzine, welche gp120 zusammen mit nef und/oder tat enthält, zur immunisierung gegen hiv
YU68602A (sh) Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
CY1105629T1 (el) Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv
EA200400197A1 (ru) Способы получения поливалентных бактериофагов для лечения бактериальных инфекций
CY1106200T1 (el) Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους
TW200621800A (en) Human immunodeficiency virus vaccine
HRP20030701A2 (en) Natural antibodies active against hiv virus
AU2003255866A8 (en) Gp41 epitope and uses thereof for the treatment of hiv infections
FR2819256B1 (fr) Polypeptide induisant des anticorps neutralisant le vih
FR2839721B1 (fr) Antigene polypeptidique induisant des anticorps neutralisant le vih
RU2001107405A (ru) Способ повышения статокинетической устойчивости человека
ES2195861T3 (es) Uso de (ir,4s)-4-(6-amino-9h-purin-9-il)-2-ciclopenten-1-metanol en vhb.
AU2001270226A1 (en) Tolerance and chronic hepatitis c virus
CY1108543T1 (el) Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC